Pictet Asset Management (Switzerland)’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $7.69M | Sell |
1,809,261
-256,915
| -12% | -$1.09M | 0.01% | 679 |
|
|
2023
Q1 | $11M | Sell |
2,066,176
-487,702
| -19% | -$2.59M | 0.01% | 595 |
|
|
2022
Q4 | $16M | Sell |
2,553,878
-737,020
| -22% | -$4.63M | 0.02% | 493 |
|
|
2022
Q3 | $34.7M | Buy |
3,290,898
+601,671
| +22% | +$6.35M | 0.05% | 333 |
|
|
2022
Q2 | $14.6M | Buy |
2,689,227
+4,679
| +0.2% | +$25.4K | 0.02% | 515 |
|
|
2022
Q1 | $24.6M | Buy |
2,684,548
+768,117
| +40% | +$7.05M | 0.03% | 449 |
|
|
2021
Q4 | $28.9M | Sell |
1,916,431
-48,276
| -2% | -$728K | 0.03% | 446 |
|
|
2021
Q3 | $46.9M | Buy |
+1,964,707
| New | +$46.9M | 0.05% | 345 |
|